Cargando…

Clopidogrel and interaction with proton pump inhibitors: comparison between cohort and within person study designs

Objective To measure the association between use of proton pump inhibitors and a range of harmful outcomes in patients using clopidogrel and aspirin. Design Observational cohort study and self controlled case series. Setting United Kingdom General Practice Research Database with linked data from the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Douglas, Ian J, Evans, Stephen J W, Hingorani, Aroon D, Grosso, Anthony M, Timmis, Adam, Hemingway, Harry, Smeeth, Liam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3392956/ https://www.ncbi.nlm.nih.gov/pubmed/22782731 http://dx.doi.org/10.1136/bmj.e4388

Ejemplares similares

Oral Bisphosphonates and Risk of Atrial Fibrillation and Flutter in Women: A Self-Controlled Case-Series Safety Analysis
por: Grosso, Anthony, et al.
Publicado: (2009)

Data Resource Profile: Cardiovascular disease research using linked bespoke studies and electronic health records (CALIBER)
por: Denaxas, Spiros C, et al.
Publicado: (2012)

Prognostic models for stable coronary artery disease based on electronic health record cohort of 102 023 patients
por: Rapsomaniki, Eleni, et al.
Publicado: (2014)

Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people
por: Rapsomaniki, Eleni, et al.
Publicado: (2014)

Impact of proton pump inhibitors on efficacy of clopidogrel: Review of evidence
por: Mistry, Suresh D., et al.
Publicado: (2011)

Impact of Proton Pump Inhibitor Therapy on the Efficacy of Clopidogrel in the CAPRIE and CREDO Trials
por: Dunn, Steven P., et al.
Publicado: (2013)

The interaction between clopidogrel and proton pump inhibitors (PPI): is there any clinical relevance?
por: Sharma, Rakesh K, et al.
Publicado: (2010)

Association between clinical presentations before myocardial infarction and coronary mortality: a prospective population-based study using linked electronic records
por: Herrett, Emily, et al.
Publicado: (2014)

Interaction between clopidogrel and proton-pump inhibitors and management strategies in patients with cardiovascular diseases
por: Gurbel, Paul A, et al.
Publicado: (2010)

The potential interaction between clopidogrel and proton pump inhibitors: a systematic review
por: Lima, Joao Paulo de Aquino, et al.
Publicado: (2010)

Fulfilling the Promise of Personalized Medicine? Systematic Review and Field Synopsis of Pharmacogenetic Studies
por: Holmes, Michael V., et al.
Publicado: (2009)

Genetics of Ischaemic Stroke among Persons of Non-European Descent: A Meta-Analysis of Eight Genes Involving ∼ 32,500 Individuals
por: Ariyaratnam, Roshan, et al.
Publicado: (2007)

Type and timing of heralding in ST-elevation and non-ST-elevation myocardial infarction: an analysis of prospectively collected electronic healthcare records linked to the national registry of acute coronary syndromes
por: Herrett, Emily, et al.
Publicado: (2013)

Impact of Concomitant Use of Proton Pump Inhibitors and Clopidogrel on Recurrent Stroke and Myocardial Infarction
por: Lee, Yong Kang, et al.
Publicado: (2023)

Threshold Haemoglobin Levels and the Prognosis of Stable Coronary Disease: Two New Cohorts and a Systematic Review and Meta-Analysis
por: Shah, Anoop D., et al.
Publicado: (2011)

Antipsychotic drugs and risks of myocardial infarction: a self-controlled case series study
por: Brauer, Ruth, et al.
Publicado: (2015)

Red Blood Cell Transfusion and Mortality in Trauma Patients: Risk-Stratified Analysis of an Observational Study
por: Perel, Pablo, et al.
Publicado: (2014)

Could NICE guidance on the choice of blood pressure lowering drugs be simplified?
por: Sofat, Reecha, et al.
Publicado: (2012)

Time spent at blood pressure target and the risk of death and cardiovascular diseases
por: Chung, Sheng-Chia, et al.
Publicado: (2018)

Changes in Practice Patterns of Clopidogrel in Combination with Proton Pump Inhibitors after an FDA Safety Communication
por: Guérin, Annie, et al.
Publicado: (2016)

Translating genomics into improved healthcare
por: Hingorani, Aroon D, et al.
Publicado: (2010)

Closing the mortality gap after a myocardial infarction in people with and without chronic obstructive pulmonary disease
por: Rothnie, Kieran J, et al.
Publicado: (2015)

Predicting mortality after acute coronary syndromes in people with chronic obstructive pulmonary disease
por: Rothnie, Kieran J, et al.
Publicado: (2016)

Effect of proton pump inhibitors on platelet inhibition activity of clopidogrel in Chinese patients with percutaneous coronary intervention
por: Kwan, Joanne, et al.
Publicado: (2011)

Clopidogrel and proton pump inhibitor (PPI) interaction: separate intake and a non-omeprazole PPI the solution?
por: Kenngott, S, et al.
Publicado: (2010)

Outcome of stroke patients on clopidogrel plus proton-pump inhibitors: a single-center cohort study
por: Alghamdi, Rahaf A., et al.
Publicado: (2019)

Proton Pump Inhibitor and Clopidogrel Use After Percutaneous Coronary Intervention and Risk of Major Cardiovascular Events
por: Maret-Ouda, John, et al.
Publicado: (2021)

Impact of concomitant use of proton pump inhibitors and clopidogrel or ticagrelor on clinical outcomes in patients with acute coronary syndrome
por: Yan, Yan, et al.
Publicado: (2016)

Completeness and diagnostic validity of recording acute myocardial infarction events in primary care, hospital care, disease registry, and national mortality records: cohort study
por: Herrett, Emily, et al.
Publicado: (2013)

Ethnicity and the first diagnosis of a wide range of cardiovascular diseases: Associations in a linked electronic health record cohort of 1 million patients
por: George, Julie, et al.
Publicado: (2017)

Use of Clopidogrel and Proton Pump Inhibitors Alone or in Combinations in Persons with Diabetes in Denmark; Potential for CYP2C19 Genotype-Guided Drug Therapy
por: Westergaard, Niels, et al.
Publicado: (2021)

Improving vascular health: are pills the answer?
por: Smeeth, Liam, et al.
Publicado: (2012)

Prognosis of concomitant users of clopidogrel and proton-pump inhibitors in a high-risk population for upper gastrointestinal bleeding
por: Wang, Qing, et al.
Publicado: (2014)

Influence of individual proton pump inhibitors on clinical outcomes in patients receiving clopidogrel following percutaneous coronary intervention
por: Lee, Dongyoung, et al.
Publicado: (2021)

Prescription behavior for gastroprotective drugs in new users as a result of communications regarding clopidogrel – proton pump inhibitor interaction
por: Kruik‐Kollöffel, Willemien J., et al.
Publicado: (2016)

The Genetics of Primary Haemorrhagic Stroke, Subarachnoid Haemorrhage and Ruptured Intracranial Aneurysms in Adults
por: Peck, George, et al.
Publicado: (2008)

Incidence of cardiovascular events and gastrointestinal bleeding in patients receiving clopidogrel with and without proton pump inhibitors: an updated meta-analysis
por: Cardoso, Rhanderson N, et al.
Publicado: (2015)

Investigation of the interaction between proton pump inhibitors and clopidogrel using VerifyNow P2Y12 assay
por: Lin, Sheng-Feng, et al.
Publicado: (2020)

Influenza Infection and Risk of Acute Myocardial Infarction in England and Wales: A CALIBER Self-Controlled Case Series Study
por: Warren-Gash, Charlotte, et al.
Publicado: (2012)

Heterogeneous associations between smoking and a wide range of initial presentations of cardiovascular disease in 1 937 360 people in England: lifetime risks and implications for risk prediction
por: Pujades-Rodriguez, Mar, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ofnuvb3qiu3cdu1fhp5gakehgm